Pulse lineResearch With Heart Logo

Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.

TitleMulti-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation.
Publication TypeJournal Article
Year of Publication2022
AuthorsMahajan A, Spracklen CN, Zhang W, et al.
Corporate AuthorsFinnGen, eMERGE Consortium
JournalNat Genet
Volume54
Issue5
Pagination560-572
Date Published2022 05
ISSN1546-1718
KeywordsDiabetes Mellitus, Type 2, Ethnicity, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Polymorphism, Single Nucleotide, Risk Factors
Abstract

We assembled an ancestrally diverse collection of genome-wide association studies (GWAS) of type 2 diabetes (T2D) in 180,834 affected individuals and 1,159,055 controls (48.9% non-European descent) through the Diabetes Meta-Analysis of Trans-Ethnic association studies (DIAMANTE) Consortium. Multi-ancestry GWAS meta-analysis identified 237 loci attaining stringent genome-wide significance (P < 5 × 10), which were delineated to 338 distinct association signals. Fine-mapping of these signals was enhanced by the increased sample size and expanded population diversity of the multi-ancestry meta-analysis, which localized 54.4% of T2D associations to a single variant with >50% posterior probability. This improved fine-mapping enabled systematic assessment of candidate causal genes and molecular mechanisms through which T2D associations are mediated, laying the foundations for functional investigations. Multi-ancestry genetic risk scores enhanced transferability of T2D prediction across diverse populations. Our study provides a step toward more effective clinical translation of T2D GWAS to improve global health for all, irrespective of genetic background.

DOI10.1038/s41588-022-01058-3
Alternate JournalNat Genet
PubMed ID35551307
PubMed Central IDPMC9179018
Grant ListR01 DK078616 / DK / NIDDK NIH HHS / United States
086113 / WT_ / Wellcome Trust / United Kingdom
064890 / WT_ / Wellcome Trust / United Kingdom
200837 / WT_ / Wellcome Trust / United Kingdom
R01 HL142302 / HL / NHLBI NIH HHS / United States
220457 / WT_ / Wellcome Trust / United Kingdom
098381 / WT_ / Wellcome Trust / United Kingdom
U01 DK078616 / DK / NIDDK NIH HHS / United States
090367 / WT_ / Wellcome Trust / United Kingdom
UM1 DK078616 / DK / NIDDK NIH HHS / United States
203141 / WT_ / Wellcome Trust / United Kingdom
084723 / WT_ / Wellcome Trust / United Kingdom
R01 DK039311 / DK / NIDDK NIH HHS / United States
U01 DK085545 / DK / NIDDK NIH HHS / United States
088158 / WT_ / Wellcome Trust / United Kingdom
101630 / WT_ / Wellcome Trust / United Kingdom
090532 / WT_ / Wellcome Trust / United Kingdom
K99 AG066849 / AG / NIA NIH HHS / United States
206194 / WT_ / Wellcome Trust / United Kingdom
212284 / WT_ / Wellcome Trust / United Kingdom
R01 DK098032 / DK / NIDDK NIH HHS / United States
212946 / WT_ / Wellcome Trust / United Kingdom
202922 / WT_ / Wellcome Trust / United Kingdom
072960 / WT_ / Wellcome Trust / United Kingdom
104085 / WT_ / Wellcome Trust / United Kingdom
R01 HL105756 / HL / NHLBI NIH HHS / United States
U01 DK105535 / DK / NIDDK NIH HHS / United States
101033 / WT_ / Wellcome Trust / United Kingdom
083948 / WT_ / Wellcome Trust / United Kingdom
098051 / WT_ / Wellcome Trust / United Kingdom
212259 / WT_ / Wellcome Trust / United Kingdom
085475 / WT_ / Wellcome Trust / United Kingdom
200186 / WT_ / Wellcome Trust / United Kingdom
R01 DK090111 / DK / NIDDK NIH HHS / United States
095101 / WT_ / Wellcome Trust / United Kingdom
106130 / WT_ / Wellcome Trust / United Kingdom
098017 / WT_ / Wellcome Trust / United Kingdom
098395 / WT_ / Wellcome Trust / United Kingdom